reports
Relevium’s CEO Issues Letter of Clarification to Shareholders Â
Relevium’s CEO Issues Letter of Clarification to Shareholders MONTREAL, July 03, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “”, OTCQB: “” and Frankfurt: “”) (the “Company” or “Relevium”), announced today a letter from Aurelio Useche, CEO to shareholders to clarify misconceptions and rumours in the market about a by the Company pursuant to a request from the OTC Markets Group. Dear shareholders, The Management of Relevium or any publicly traded company has the responsibility to dispel unfounded rumours, misinformation or false statements which result in unusual market...
Relevium Issues Statement Regarding Recent Promotional Activity
Relevium Issues Statement Regarding Recent Promotional Activity MONTREAL, July 01, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “”, OTCQB: “” and Frankfurt: “”) (the “Company” or “Relevium”), announced today that it has been made aware of and requested by the OTC Markets Group, Inc. to comment on recent promotional activity concerning its common shares traded on the OTCQB market. On June 27th, 2019, the OTC Markets Group sent the Company copies of three newsletters sent on June 25 and June 26, 2019 by SmallCapFirm, a third-party marketing and awareness firm utilized by Sto...
Relevium Acquires Exclusive Licence From California Based Cannakids®
Relevium Acquires Exclusive Licence From California Based Cannakids® MONTREAL, May 30, 2019 (GLOBE NEWSWIRE) -- Inc. (TSX.V:”, OTCQB:“” and Frankfurt: ”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary Biocannabix Health Corporation Inc., has completed necessary compliance process and obligations for the acquisition for exclusive licensing with cannabis company Cannakids®. The Company’s Pediatric Cannabinoid Strategy Biocannabix Health Corporation, a wholly-owned subsidiary of Relevium is focusing on delivering all the potential health ben...
Relevium Announces DTC Eligibility for the US Market
Relevium Announces DTC Eligibility for the US Market MONTREAL, Feb. 08, 2019 (GLOBE NEWSWIRE) -- (TSX.V: “”, OTC: “” and Frankfurt: “”) (the “Company” or “Relevium”) is pleased to announce it has secured eligibility by The Depository Trust Company (DTC) for its shares on the OTC. DTC is a subsidiary of the Depository Trust & Clearing Corp. that manages the electronic clearing and settlement of publicly traded companies in the United States. DTC eligibility will simplify the process of trading and is expected to enhance liquidity and overall visibility in the US OTC capital markets, whe...
Relevium to Acquire Multi-Brand Company in the UK
Relevium to Acquire Multi-Brand Company in the UK MONTREAL, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Inc. (TSX.V:“”, OTCQB:“” and Frankfurt: “”) (the “Company” or “Relevium”), is pleased to announce it has executed a binding agreement to acquire 100% of the shares of Sleipnir Nutrition Ltd. (“Sleipnir”), a UK health and wellness multi-brand portfolio entrepreneurial company with products in superfood teas, skin care and beauty. The transaction is expected to close before the end of this month. “We are excited to continue to strengthen our branding and global reach capabilities with the strateg...
Relevium Announces the National Screening of “Weed the People†Mo...
Relevium Announces the National Screening of “Weed the People” Movie Across Eight Major Cities MONTREAL, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Inc. (TSX.V:“”, OTCQB:“” and Frankfurt: “”) (the “Company” or “Relevium”), is pleased to announce the national screening of “Weed the People” across eight Canadian cities on January 15, 2019. Relevium Technologies, in partnership with Executive Producer Ricki Lake, Director Abby Epstein and Cannakids.org, will be conducting a nation-wide screening of Weed the People, a compelling, emotional and educational film that explores the potential benefits o...
Relevium Launches Its Leefylyfeâ„¢ Organically Sourced Whole Plant Hem...
Relevium Launches Its Leefylyfe™ Organically Sourced Whole Plant Hemp Derived CBD Products in the UK MONTREAL, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has launched its brand of organically sourced full spectrum hemp CBD products on a pre-order basis in the UK. The Company is launching three initial organically sourced, whole plant Hemp CBD rich oils in product and tincture formats that maintain a full spectrum of secondary cannabinoids, terpene profiles and flavonoids for wel...
Relevium Launches 30 New Bioganix® Gold Brand Products in Walmart.com
Relevium Launches 30 New Bioganix® Gold Brand Products in Walmart.com MONTREAL, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Inc. (TSX.V:“”, OTCQB:“” and Frankfurt: “”) (the “Company” or “Relevium”) is pleased to announce that it has launched 30 new exclusive products under its Bioganix® Gold Brand in Walmart.com On it was targeting to launch 30 new products under its Bioganix® Gold Brand, which sell exclusively in Walmart.com. The Company has launched 14 out of the 30 new products and the balance is currently under the normal compliance review process and are expected to be live on over the...
Relevium Technologies Signs JV With Holistic Industries for Biocannabi...
Relevium Technologies Signs JV With Holistic Industries for Biocannabix Health Corporation MONTREAL, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Inc. (TSX.V:“”, OTCQB:“” and Frankfurt: “”) (the “Company” or “Relevium”) is pleased to announce it has executed a letter of intent to form a partnership with to jointly develop Biocannabix Health Corp, the pediatric and geriatric focused biopharma subsidiary of Relevium Technologies. “We are very pleased to partner with one the pioneers and leaders in medical cannabis in the US. The win-win strategy of leveraging the many years of experience from H...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.